FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

Posted on


  1. FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults  FDA.gov
  2. First blood test to help diagnose brain injuries gets US OK  ABC News
  3. FDA OKs new blood test for concussions  Seeking Alpha
  4. Full coverage



Days ago The U.S. Food and Drug Administration today permitted marketing of the first blood test to evaluate mild traumatic brain injury mTBI , commonly referred to as concussion, in adults. The FDA reviewed and authorized for marketing the Banyan Brain Trauma Indicator in fewer than months as part of its .Days ago Citation s . FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults. Silver Spring, MD. US Food and Drug Administration. . PressAnnouncements ucm.htm .Days ago After deliberations that took less than six months, the FDA approved the marketing of the Banyan Brain Trauma Indicator to aid the evaluation of concussions in adults. The speedy approval of such a blood test, after it was assigned the FDA designation of a "breakthrough" product, is expected to drive down .Days ago Today, the FDA approved the marketing of the first blood test to assess concussion in adults, known as the Brain Trauma Indicator, according to a press "A blood test to aid in concussion evaluation is an important tool for the American public and for our service members abroad who need access to quick .







Leave a Reply

Your email address will not be published. Required fields are marked *